Navigation Links
Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
Date:4/11/2013

nts already being treated with optimal medical therapy, including diuretics.  CLP-1001 has the potential to provide additional sodium and fluid removal independent of the kidneys, making it an attractive alternative therapy.

About Sorbent
Sorbent Therapeutics is a private biopharmaceutical company developing therapies for patients requiring targeted cation and fluid removal from the body.  The company is focused on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, end-stage renal disease, chronic kidney disease and hypertension.  Sorbent is headquartered in Sunnyvale, California.  For more information, visit www.sorbent.com.


'/>"/>
SOURCE Sorbent Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sorbent Therapeutics CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study
2. Sorbent Therapeutics Presents CLP1001 Phase 2a Study Results at the 16th Annual Meeting of the Heart Failure Society of America
3. Sorbent Therapeutics Appoints Jason Levin Chief Business Officer
4. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
5. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
6. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015   Cochlear Limited ... hearing solutions, announced today the US Food and ... Profile™ Implant with Slim Straight Electrode (CI522). Built ... in close collaboration with the world,s leading surgeons, ... platform designed to provide the most discreet appearance ...
(Date:7/1/2015)... 24, 2015 ... the addition of the "2015 New ... Markets: Business Challenges, Emerging Technologies, Competitive Landscape" ... 2015 New Frontiers in European Clinical Chemistry ... Competitive Landscape is a new five-country strategic ...
(Date:7/1/2015)... July 1, 2015  goBalto, Inc., the leading ... today unprecedented growth in serving pharmaceutical, biotech and ... to speed clinical trials and restrain costs, but ... methods have stalled these efforts," said Sujay ... clinical trials has encouraged Industry leaders, to embrace ...
Breaking Medicine Technology:Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 32015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 2goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2
... 2011 Aerocrine, Inc., an innovative medical technology company ... has selected R&J Public Relations, LLC of Bridgewater, N.J., ... conduct strategic public relations for the Aerocrine brand; most ... and only hand-held device available to measure exhaled nitric ...
... Reportlinker.com announces that a new market research report ... Telemedicine: Opportunities for Medical and Electronic Providers ... global telemedicine market is expected to grow from $9.8 ... a compound annual growth rate (CAGR) of 18.6% over ...
Cached Medicine Technology:R&J Public Relations Named Agency of Record for Aerocrine, Inc. 2Reportlinker Adds Telemedicine: Opportunities for Medical and Electronic Providers 2Reportlinker Adds Telemedicine: Opportunities for Medical and Electronic Providers 3Reportlinker Adds Telemedicine: Opportunities for Medical and Electronic Providers 4Reportlinker Adds Telemedicine: Opportunities for Medical and Electronic Providers 5
(Date:7/2/2015)... ... ... DUI arrests and fatalities spike on the 4th of July. In fact, because of drunk ... comes to being on the road. According to attorney David J. Maloney , the ... highway deaths between 2007 and 2011 were caused by drunk driving over the 4th of ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... It’s no secret that what we consume can have an effect on ... people can easily feel dehydrated or perhaps even undernourished if not eating enough of the right ... can be an easy time of year to overdo it on the food front as well, ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... To Resource" for Semiconductor Timing announced the release and publication of their newest ... a Quarterly based publication and Newsletter. , Designed in support of coverage ...
(Date:7/1/2015)... Angeles, CA (PRWEB) , ... July 01, 2015 , ... ... the great outdoors. Yet, in many Middle-Eastern countries like Saudi Arabia and Dubai, the ... to relax in more temperate climates. Celebrity dentist Dr. Sam Saleh of ORA Dentistry ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... of Levaquin ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion for Summary Judgment. ... West Virginia on June 26th, the Court rejected the Plaintiff’s assertion that ...
Breaking Medicine News(10 mins):Health News:Attorney David Maloney Stresses Safety through Sobriety 2Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3
... Raises Caution on Using Signal Transduction Inhibitors,in Children -, ... eliminated brain tumors from mice in a dramatic 2004 ... damage in younger mice. The,researcher who conducted both studies ... drugs to treat children,s cancers, at,least until there is ...
... All Stages Steps Away From Home, ... ... of,South Carolina (MUSC) Foundation for Research and Development announced a,promising new ... cancer have shown to be accurate for only 40 percent of,diagnoses. ...
... DC (March 5, 2008): Addressing questions about climate change, ... in a recent survey, Student Pugwash USA launched From ... to the 2008 elections. , From Electrons to ... voters on science, technology, and health issues and provide ...
... CITY, March 10 ZARS Pharma, Inc. ... Galderma Pharma S.A. the,exclusive promotion and distribution ... and Canada for Pliaglis(TM) (lidocaine and tetracaine) ... and safe local,anesthesia in patients undergoing potentially ...
... Scientists have established a mouse model for human malignant ... development and progression along with new directions for design ... in the March issue of Cancer Cell, may eventually ... this devastating disease. , MM is an aggressive ...
... that can occur in babies with congenital heart disease is the ... results in too much blood in the lungs, more blood vessels ... vessel growth is abruptly halted. , You get this burst in ... think the system gets shut down and the lungs dont get ...
Cached Medicine News:Health News:Potential Brain Cancer Drug for Children May Damage Bones 2Health News:Potential Brain Cancer Drug for Children May Damage Bones 3Health News:Cell Receptor on Track for Painless Bladder Cancer Test 2Health News:Student Pugwash USA launches science policy election guide for young voters 2Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 2Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 3Health News:Mouse model for mesothelioma reproduces human disease 2Health News:Lung damage in babies with congenital heart disease under study 2Health News:Lung damage in babies with congenital heart disease under study 3
... PDA Closure Device has been developed for ... Arteriosus. Introduced through standard venous sheaths (10-14F) ... method for the percutaneous closure of persistent ... within the ductus.,An integral locking delivery and ...
Stainless steel plain Steinman Pins available in point types A through F....
Full pin skeletal traction pins with cove point....
Calibrated Guide Pins have a 12.7 mm calibration and are available in plain, with a threaded tip, or with a trocar point....
Medicine Products: